Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons

Journal of Virology

Volumn 81, Issue 13, 2007, Pages 7124-7135

  Moraes, Mauro Pires ^a   De Los Santos, Teresa ^a   Koster, Maria ^a   Turecek, Traci ^a   Wang, He ^a   Andreyev, Vladimir G ^a,b   Grubman, Marvin J ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b Federal Centre for Animal Health (FGI ARRIAH)   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE INDUCTION; HUMAN; HUMAN CELL; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SWINE DISEASE; TREATMENT RESPONSE; VIREMIA; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CELL LINE; CRICETINAE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; SHEEP; SWINE; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; HUMAN ADENOVIRUS TYPE 5; SUIDAE; SUS;

EID: 34250840521     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02775-06     Document Type: Article

References (79)

1. Adams, O., K. Beskin, C. Oberdorfer, C. R. MacKenzie, O. Takikawa, and W. Daubener. 2004. Role of indoleamine 2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J. Virol. 78:2632-2636.
2. Ahl, R., and A. Rump. 1976. Assay of bovine interferons in cultures of the porcine cell line IB-RS-2. Infect. Immun. 14:603-606.
3. Anonymous. 2002. Infectious disease in livestock. The Royal Society, London, United Kingdom.
4. Anonymous. 2004. Foot and mouth disease, p. 111-128. In Manual of diagnostic tests and vaccines for terrestrial animals, 5th ed., vol. 1. OIE Biological Standard Commission, Paris, France.
5. Arai, K., Z. X. Liu, T. E. Lane, and G. Dennert. 2002. IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver. Cell. Immunol. 219:48-56.
6. Balish, M. J., M. E. Abrams, A. M. Pumfery, and C. R. Brandt. 1992. Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and -gamma. J. Infect. Dis. 166:1401-1403.
7. Basler, C. F., and A. Garcia-Sastre. 2002. Viruses and the type I interferon antiviral system: induction and evasion. Int. Rev. Immunol. 21:305-337.
8. Bautista, E. M., D. Gregg, and W. T. Golde. 2002. Characterization and functional analysis of skin-derived dendritic cells from swine without a requirement for in vitro propagation. Vet. Immunol. Immunopathol. 88:131-148.
9. Biron, C. A., and G. C. Sen. 2001. Interferons and other cytokines, p. 321-351. In D. M. Knipe, P. H. Howley, D. E. Griffin, M. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
10. Bodaghi, B., O. Goueau, D. Zipeto, L. Laurent, J.-L. Virelizier, and S. Michelson. 1999. Role of IFN-gamma-induced indolamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162:957-964.
11. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129-134.
12. Burrows, R. 1966. The foot-and-mouth disease virus in pigs. J. Hyg. (Cambridge) 64:419-429.
13. Cantin, E., B. Tanamachi, and H. Openshaw. 1999. Role for gamma interferon in control of herpes simplex virus type I reactivation. J. Virol. 73:3418-3423.
14. Caron, L., M. C. S. Brum, M. P. Moraes, W. T. Golde, C. W. Arns, and M. J. Grubman. 2005. The effect of granulocyte-macrophage colony-stimulating factor on the potency and efficacy of a foot-and-mouth disease virus subunit vaccine. Pesqui. Vet. Bras. 25:150-158.
15. Cedillo-Barron, L., M. Foster-Cuevas, G. J. Belsham, F. Lefevre, and R. M. Parkhouse. 2001. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J. Gen. Virol. 82:1713-1724.
16. Cheney, I. W., V. C. H. Lai, W. Zhong, T. Brodhag, S. Dempsey, C. Lim, Z. Hong, J. Y. N. Lau, and R. C. Tam. 2002. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J. Virol. 76:11148-11154.
17. Chesler, D. A., and C. S. Reiss. 2002. The role of IFN-gamma in immune response to viral infections of the central nervous system. Cytokine Growth Factor Rev. 13:441-454.
18. Chinsangaram, J., M. Koster, and M. J. Grubman. 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75:5498-5503.
19. Chinsangaram, J., M. P. Moraes, M. Koster, and M. J. Grubman. 2003. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 77:1621-1625.
20. Chinsangaram, J., M. E. Piccone, and M. J. Grubman. 1999. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73:9891-9898.
21. Conzelmann, K.-K. 2005. Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J. Virol. 79:5241-5248.
22. de Avila Botton, S., M. C. S. Brum, E. Bautista, M. Koster, R. Weiblen, W. T. Golde, and M. J. Grubman. 2006. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24:3446-3456.
23. de los Santos, T., S. de Avila Botton, R. Weiblen, and M. J. Grubman. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80:1906-1914.
24. Der, S. D., A. Zhou, B. R. G. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.
25. Desloges, N., M. Rahaus, and M. H. Wolff. 2005. Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon. J. Gen. Virol. 86:1-6.
26. Devaney, M. A., V. N. Vakharia, R. E. Lloyd, E. Ehrenfeld, and M. J. Grubman. 1988. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap binding protein complex. J. Virol. 62:4407-4409.
27. Doel, T. R., M. Lombard, D. Fawthrop, C. Schermbrucker, and P. Dubourget. 1998. Testing of FMD vaccines. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Aldershot, United Kingdom, 14 to 18 September 1998. Food and Agriculture Organization, Rome, Italy.
28. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-γ-inducible protein 10 (IP-10: CXCL10)-deficient mice reveal a role for immnoprecipitation-10 in effector T-cell generation and trafficking. J. Immunol. 168:3195-3204.
29. Frese, M., V. Schwarze, K. Barth, N. Kriegr, V. Lohmann, S. Mihm, O. Haller, and R. Bartenschlager. 2002. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35:694-703.
30. Fuchizaki, U., S. Kaneko, Y. Nakamoto, Y. Sugiyama, K. Imagawa, M. Kikuchi, and K. Kobayashi. 2003. Synergistic antiviral effect of a combination of mouse interferon-α and interferon-γ on mouse hepatitis virus. J. Med. Virol. 69:188-194.
31. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J. Gen. Virol. 81:2341-2364.
32. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36:59-72.
33. Grubman, M. J. 2005. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Biologicals 33:227-234.
34. Grubman, M. J., and B. Baxt. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493.
35. Hartshorn, K. L., D. Neumeyer, M. W. Vogt, R. T. Schooley, and M. S. Hirsch. 1987. Activities of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res. Hum. Retrovir. 3:125-133.
36. Henke, A., R. Zell, G. Ehrlich, and A. Stelzner. 2001. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. J. Virol. 75:8187-8194.
37. Henke, A., R. Zell, U. Martin, and A. Stelzner. 2003. Direct interferon-γ-mediated protection caused by a recombinant coxsackievirus B3. Virology 315:335-344.
38. Hokeness, K. L., W. A. Kuziel, C. A. Biron, and T. P. Salazar-Mather. 2005. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-α/β-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174:1549-1556.
39. Horwitz, M. S., T. Krahl, C. Fine, J. Lee, and N. Sarvetnick. 1999. Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J. Virol. 73:1756-1766.
40. Kakimi, K., T. E. Lane, S. Wieland, V. C. Asensio, I. L. Campbell, F. V. Chisari, and L. G. Guidotti. 2001. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 194:163-172.
41. Karupiah, G., R. V. Blanden, and I. A. Ramshaw. 1990. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J. Exp. Med. 172:1495-1503.
42. Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687.
43. Komatsu, T., Z. Bi, and C. S. Reiss. 1996. Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:101-108.
44. Levy, D. E., D. J. Lew, T. Decker, D. S. Kessler, and J. E. Darnell, Jr. 1990. Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J. 9:1105-1111.
45. Liao, P. C., Y. L. Lin, M. H. Jong, and W. B. Chung. 2003. Efficacy of foot-and-mouth disease vaccine in pigs with single dose immunization. Vaccine 21:1807-1810.
46. Liu, G. Q., Shai, D. J. Schaffner, A. Wu, A. Yohannes, T. M. Robinson, M. Maland, J. Wells, T. G. Voss, C. Bailey, and K. Alibek. 2004. Prevention of lethal respiratory vaccinia infections in mice with interferon-α and interferon-γ. FEMS Immunol. Med. Microbiol. 40:201-206.
47. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. C. Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963-969.
48. Mason, P. W., M. E. Piccone, T. S. McKenna, J. Chinsangaram, and M. J. Grubman. 1997. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227:96-102.
49. Matsumoto, M., N. Tanaka, H. Harada, T. Kimura, T. Yokochi, M. Kitagawa, C. Schindler, and T. Taniguchi. 1999. Activation of the transcription factor ISGF3 by interferon-gamma. Biol. Chem. 380:699-703.
50. Mayr, G. A., J. Chinsangaram, and M. J. Grubman. 1999. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263:496-506.
51. Meyer, R. F., G. D. Babcock, J. F. Newman, T. G. Burrage, K. Toohey, J. Lubroth, and F. Brown. 1997. Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals. J. Virol. Methods 65:33-43.
52. Moraes, M. P., J. Chinsangaram, M. C. S. Brum, and M. J. Grubman. 2003. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22:268-279.
53. Moraes, M. P., G. A. Mayr, and M. J. Grubman. 2001. pAd5-Blue: an easy to use, efficient, direct ligation system for engineering recombinant adenovirus constructs. BioTechniques 31:1050-1056.
54. Moraes, M. P., G. A. Mayr, P. W. Mason, and M. J. Grubman. 2002. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20:1631-1639.
55. Muruve, D. A. 2004. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15:1157-1166.
56. Muruve, D. A., M. J. Barnes, I. E. Stillman, and T. A. Libermann. 1999. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10:965-976.
57. Obojes, K., O. Andres, K. S. Kim, W. Daubener, and J. Schneider-Schaulies. 2005. Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J. Virol. 79:7768-7776.
58. Okuse, C., J. A. Rinaudo, K. Farrar, F. Wells, and B. E. Korba. 2005. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Antivir. Res. 65:23-34.
59. Pacheco, J. M., M. C. S. Brum, M. P. Moraes, W. T. Golde, and M. J. Grubman. 2005. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus vectored FMDV subunit vaccine. Virology 337:205-209.
60. Sa-Carvalho, D., E. Rieder, B. Baxt, R. Rodarte, A. Tanuri, and P. W. Mason. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71:5115-5123.
61. Sainz, B., Jr., and W. P. Halford. 2002. Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type J. J. Virol. 76:11541-11550.
62. Sainz, B., Jr., H. L. LaMarca, R. F. Garry, and C. A. Morris. 2005. Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/ beta and interferon-gamma. Virol. J. 2:14.
63. Sainz, B., Jr., E. C. Mossel, C. J. Peters, and R. F. Garry. 2004. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 329:11-17.
64. Salazar-Mather, T. P., and K. L. Hokeness. 2003. Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks. Viral Immunol. 16:291-306.
65. Salazar-Mather, T. P., and K. L. Hokeness. 2006. Cytokine and chemokine networks: pathways to antiviral defense. Curr. Topics Microbiol. Immunol. 303:29-46.
66. Sanz-Parra, A., M. A. Jimenez-Clavero, M. M. Garcia-Briones, E. Blanco, F. Sobrino, and V. Ley. 1999. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology 259:129-134.
67. Saura, M., C. Zaragoza, A. McMillan, R. A. Quick, C. Hohenadl, J. M. Lowenstein, and C. J. Lowenstein. 1999. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 10:21-28.
68. Scudamore, J. M., and D. M. Harris. 2002. Control of foot and mouth disease: lessons from the experience of the outbreak in Great Britain in 2001. Rev. Sci. Tech. Off. Int. Epizoot. 21:699-710.
69. Shrestha, B., T. Wang, M. A. Samuel, K. Whitby, J. Craft, E. Fikrig, and M. S. Diamond. 2006. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 80:5338-5348.
70. Sorensen, K. J., K. de Strieker, K. C. Dyrting, S. Grazioli, and B. Haas. 2005. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody. Arch. Virol. 150: 805-814.
71. Taub, D. D., T. J. Sayers, C. R. D. Carter, and J. R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-3888.
72. Thomas, D. C., and C. E. Samuel. 1992. Mechanism of interferon action: alpha and gamma interferons differentially affect mRNA levels of the catalytic subunit of protein kinase A and protein Mx in human cells. J. Virol. 66:2519-2522.
73. Trifilo, M. J., C. Montalto-Morrison, L. N. Stiles, K. R. Hurst, J. L. Hardison, J. E. Manning, P. S. Masters, and T. E. Lane. 2004. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 78:585-594.
74. Vollstedt, S., S. Arnold, C. Schwerdel, M. Franchini, G. Alber, J. P. Di Santo, M. Ackermann, and M. Sutter. 2004. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type I. J. Virol. 78:3846-3850.
75. Wang, C. Y., T. Y. Chang, A. M. Walfield, J. Ye, M. Shen, S. P. Chen, M. C. Li, Y. L. Lin, M. H. Jong, P. C. Yang, N. Chyr, E. Kramer, and F. Brown. 2002. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20:2603-2610.
76. Weber, F., G. Kochs, and O. Haller. 2004. Inverse interference: how viruses fight the interferon system. Viral Immunol. 17:498-515.
77. Wu, Q., M. C. S. Brum, L. Caron, M. Koster, and M. J. Grubman. 2003. Adenovirus-mediated type I interferon expression partially protects cattle from foot-and-mouth disease. J. Interferon Cytokine Res. 23:371-380.
78. Zaragoza, C., C. J. Ocampo, M. Saura, A. McMillan, and C. J. Lowenstein. 1997. Nitric oxide inhibition of coxsackievirus replication in vitro. J. Clin. Investig. 100:1760-1767.
79. Zhang, Z. D., G. Hutching, P. Kitching, and S. Alexandersen. 2002. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells. Arch. Virol. 147:2157-2167.